1 min read
FDA TO HOLD PUBLIC WORKSHOP ABOUT MODELING AND SIMULATION PRACTICES USED IN HEALTH TECHNOLOGIES
BMES 02/19/2020
The Food and Drug Administration will hold a public workshop entitled “Towards Good Simulation Practices in Health Technologies.” The meeting will be held April 13-15, 2020.
The purpose of the public workshop is to discuss modeling and simulation practices currently used in health technologies by industry and to develop a framework for evaluating and assessing the utility of computational modeling and simulation in health technologies, according to FDA.
To register for the workshop CLICK HERE.
The key topics to be discussed are the role of computational modeling and simulation in the regulatory evaluation of health technologies and current simulation practices. The goal of the event is to gather input to inform the development of good simulation practice recommendations, according to FDA.
The meeting will take place at the FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, MD.
The meeting will be webcasted live; CLICK HERE to register for the webcast.
There is no fee to register for the Workshop. Early registration is recommended because seating is limited. Registration will be on a first-come, first-served basis.

Gordana Vunjak-Novakovic Opens BMES Annual Meeting
This is the fifth in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024 Annual...

NIH Prize Competitions: Crowdsourcing Biomedical Innovation
This is the sixth and final article in a series highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024...

1 min read
NSF/FDA SCHOLAR-IN-RESIDENCE PROGRAM AT FDA
The National Science Foundation (NSF) and the U.S. Food and Drug Administration (FDA) have established the NSF/FDA Scholar-in-Residence Program at...

BMES INTERVIEW WITH INDUSTRY WEBINAR SERIES LAUNCHES FEB. 28
A new BMES webinar series – Interview with Industry – launches this month with a Q&A session with AbbVie Inc. Associate Director Hetal Sarvaiya.

Take Advantage of Annual Meeting Advance Registration
Did you miss early-bird pricing for the2024 BMES Annual Meeting?